The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB),
including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB
correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system.
Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly
prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.
749: We are looking to develop a corporate email that would be sent by the reps to outline the opportunity to communicate virtually with them. The layout would be corporate branded with no mention of any brands. The content simply outlines the benefits of a virtual call and how to connect/steps to make a video call. Would this type of information be exempt from PAAB review?
-
An unbranded message encouraging HCPs to reach out to reps virtually, with no additional message about therapeutic areas, brands, or services, could be considered exempt. However, there are ways to render this type of message subject to the code (e.g. corporate tagline, brand mention, service claims, therapeutic claims etc.). As such, we recommend submitting for a formal exemption review.